Carlyle and Piramal Pharma Sign Agreement on a 20% Strategic Growth Investment

     
• Transaction values the Pharma Business at an Enterprise Value (EV) of US$2,775 million 
     
• Integrate Piramal Enterprises’ Pharma businesses into its subsidiary Piramal Pharma Limited 
     
• Capital Raise to accelerate Piramal Pharma’s organic and inorganic growth plans 

PEL raises funds of ~INR 14,500 Crores in FY2020

• INR 1,750 Crores from CDPQ against preferential allotment of CCDs


• INR 3,650 Crores from the Rights Issue | Over-subscribed ~1.14 times


• INR 6,750 Crores from the sale of Decision Resources Group


• INR 2,300 Crores from the stake sale in Shriram Transport Finance

Built on the foundation of Trusteeship, Piramal Group imbibes a business ethos that believes in creating value for all its stakeholders.

Mr. Ajay Piramal Chairman, Piramal Group

Committed to its corporate philosophy of ‘Doing Well and Doing Good’, Piramal Group is focused on building innovative solutions that positively impact the larger community.

Dr. Swati Piramal Vice Chairperson, Piramal Group

Ranked Amongst
“India’s 30 Best Workplaces in Manufacturing - 2020”

Delighted to partner with NITI Aayog and launch “Surakshit Dada Dadi Nana Nani Abhiyaan” in 112 Aspirational Districts across India